Guardion Health Sciences, Inc.
DelistedCIK 1642375fmd_1WTXZTR170584DNDX27AHHH043Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2024, 35 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 1 | 1 | 2 | 7 | 11 | 12 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 7 | 7 |
| Gross profit | 0 | 0 | 0 | 1 | 1 | (0) | 3 | 5 | 5 |
| Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 6 | 4 | 5 | 6 | 9 | 9 | 14 | 12 | 9 |
| Total operating expenses | 6 | 4 | 6 | 7 | 11 | 8 | 28 | 22 | 10 |
| Operating income | (6) | (4) | (5) | (6) | (10) | (9) | (25) | (17) | (4) |
| Interest expense | 1 | 1 | 0 | 0 | 0 | 0 | – | – | – |
| Other non-operating income (expense) | – | – | (0) | 2 | (0) | (0) | 0 | 2 | 4 |
| Net income | (9) | (6) | (5) | (8) | (11) | (9) | (25) | (15) | 0 |
| Net income to common shareholders | (9) | (7) | (6) | (8) | – | – | (25) | (16) | 0 |